Citigroup’s Nymox Pharmaceutical Corp NYMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,474
| Closed | -$1K | – | 5653 |
|
|
2022
Q2 | $1K | Sell |
1,474
-107,605
| -99% | -$73K | ﹤0.01% | 5332 |
|
|
2022
Q1 | $137K | Buy |
+109,079
| New | +$137K | ﹤0.01% | 3591 |
|
|
2021
Q3 | – | Sell |
-332
| Closed | -$1K | – | 5616 |
|
|
2021
Q2 | $1K | Sell |
332
-2,799
| -89% | -$8.43K | ﹤0.01% | 5384 |
|
|
2021
Q1 | $7K | Sell |
3,131
-4,490
| -59% | -$10K | ﹤0.01% | 5158 |
|
|
2020
Q4 | $19K | Buy |
7,621
+5,613
| +280% | +$14K | ﹤0.01% | 4670 |
|
|
2020
Q3 | $5K | Sell |
2,008
-3,174
| -61% | -$7.9K | ﹤0.01% | 4700 |
|
|
2020
Q2 | $18K | Sell |
5,182
-16,788
| -76% | -$58.3K | ﹤0.01% | 4342 |
|
|
2020
Q1 | $51K | Buy |
+21,970
| New | +$51K | ﹤0.01% | 3781 |
|
|
2019
Q4 | – | Sell |
-3,652
| Closed | -$7K | – | 5237 |
|
|
2019
Q3 | $7K | Sell |
3,652
-1,226
| -25% | -$2.35K | ﹤0.01% | 4700 |
|
|
2019
Q2 | $7K | Sell |
4,878
-3,400
| -41% | -$4.88K | ﹤0.01% | 4831 |
|
|
2019
Q1 | $16K | Sell |
8,278
-3,774
| -31% | -$7.3K | ﹤0.01% | 4616 |
|
|
2018
Q4 | $16K | Buy |
12,052
+3,185
| +36% | +$4.23K | ﹤0.01% | 4501 |
|
|
2018
Q3 | $22K | Buy |
8,867
+1,121
| +14% | +$2.78K | ﹤0.01% | 4484 |
|
|
2018
Q2 | $26K | Buy |
7,746
+2,811
| +57% | +$9.44K | ﹤0.01% | 4286 |
|
|
2018
Q1 | $21K | Buy |
4,935
+820
| +20% | +$3.49K | ﹤0.01% | 4204 |
|
|
2017
Q4 | $14K | Buy |
4,115
+4,011
| +3,857% | +$13.6K | ﹤0.01% | 4389 |
|
|
2017
Q3 | $0 | Sell |
104
-85
| -45% | – | ﹤0.01% | 4923 |
|
|
2017
Q2 | $1K | Buy |
+189
| New | +$1K | ﹤0.01% | 4784 |
|
|
2016
Q1 | – | Sell |
-82
| Closed | – | – | 5679 |
|
|
2015
Q4 | $0 | Sell |
82
-1,513
| -95% | – | ﹤0.01% | 5728 |
|
|
2015
Q3 | $5K | Buy |
+1,595
| New | +$5K | ﹤0.01% | 4665 |
|
|
2014
Q2 | – | Sell |
-212
| Closed | -$1K | – | 5677 |
|
|
2014
Q1 | $1K | Buy |
212
+179
| +542% | +$844 | ﹤0.01% | 5353 |
|
|
2013
Q4 | $0 | Buy |
+33
| New | – | ﹤0.01% | 5509 |
|